Sign up to save your podcasts
Or
Share Episode 19: Patient Fundamentals - Breast cancer -Discussing CDK4/6 inhibitors in breast cancer for patients with Professor Mark Beresford.
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 19: Patient Fundamentals - Breast cancer -Discussing CDK4/6 inhibitors in breast cancer for patients with Professor Mark Beresford.
Send us a text
In this episode we discuss CDK4/6 inhibitors with Professor Mark Beresford, Clinical oncologist and chair of UK Breast cancer Group.
Mark shares his knowledge on why we are giving these drugs to patients with breast cancer and what patients can expect on them.
This is a really big group of patients and we hope this is useful for supporting them.
We hope you enjoy
John & Mike
View all episodes
By John McGrane & Michael RoweSend us a text
In this episode we discuss CDK4/6 inhibitors with Professor Mark Beresford, Clinical oncologist and chair of UK Breast cancer Group.
Mark shares his knowledge on why we are giving these drugs to patients with breast cancer and what patients can expect on them.
This is a really big group of patients and we hope this is useful for supporting them.
We hope you enjoy
John & Mike